NCT07928973 Clinical Application of a Novel Corneal Biomechanical Device in Refractive Surgery
| NCT ID | NCT07928973 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Eye Hospital |
| Condition | Corneal Biomechanics |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-11-04 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-11-04 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the accuracy of corneal Young's modulus measurements (E\_Steady-State) obtained using a steady-state corneal biomechanical measurement device in patients scheduled to undergo refractive surgery and to explore their potential applications in assisting refractive surgical procedures.
Eligibility Criteria
Inclusion Criteria: 1. Best corrected visual acuity (BCVA) ≥ 20/20; 2. No other eye diseases except myopia and astigmatism; 3. The cornea was transparent, and there was no cloud or pannus; Exclusion Criteria: 1. Corneal disease; 2. Ocular trauma; 3. Previous ocular surgery; 4. Any anterior segment diseases except cataract; 5. Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination; 6. Pregnant and lactating women;
Frequently Asked Questions
Who can join the NCT07928973 clinical trial?
This trial is open to participants of all sexes, studying Corneal Biomechanics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07928973 currently recruiting?
Yes, NCT07928973 is actively recruiting participants. Visit ClinicalTrials.gov or contact Tianjin Eye Hospital to inquire about joining.
Where is the NCT07928973 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07928973 clinical trial?
NCT07928973 is sponsored by Tianjin Eye Hospital. The trial plans to enroll 200 participants.